
Gilead is looking to several new studies to support future new Sovaldi combinations and broadened treatment groups for its hepatitis …
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals

